Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Fibroblast growth factor 11 (FGF11) is a member of the intracellular fibroblast growth factor subfamily (also called FGF homologous factors, FHFs), which includes FGF11–FGF14[5][3]. Unlike classical FGFs, FGF11 does not bind or activate fibroblast growth factor receptors (FGFRs) at the cell surface and is not secreted. Instead, FGF11 functions intracellularly, where it is involved in nervous system development and function, though its precise biological roles are not fully elucidated[3][5]. FGF11 is associated with some nervous system disorders such as developmental and epileptic encephalopathy, but it is not currently considered a therapeutic target, and there are no approved drugs or biomarkers based on this molecule[3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Fibroblast growth factor 11 (FGF11).